4.7 Article

Protein kinase C mediates platelet secretion and thrombus formation through protein kinase D2

期刊

BLOOD
卷 118, 期 2, 页码 416-424

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2010-10-312199

关键词

-

资金

  1. British Heart Foundation [RG/05/015, PG/07/118/24152]
  2. British Heart Foundation [PG/08/049/25130, RG/10/006/28299] Funding Source: researchfish

向作者/读者索取更多资源

Platelets are highly specialized blood cells critically involved in hemostasis and thrombosis. Members of the protein kinase C (PKC) family have established roles in regulating platelet function and thrombosis, but the molecular mechanisms are not clearly understood. In particular, the conventional PKC isoform, PKC alpha, is a major regulator of platelet granule secretion, but the molecular pathway from PKC alpha to secretion is not defined. Protein kinase D (PKD) is a family of 3 kinases activated by PKC, which may represent a step in the PKC signaling pathway to secretion. In the present study, we show that PKD2 is the sole PKD member regulated downstream of PKC in platelets, and that the conventional, but not novel, PKC isoforms provide the upstream signal. Platelets from a gene knock-in mouse in which 2 key phosphorylation sites in PKD2 have been mutated (Ser707Ala/Ser711Ala) show a significant reduction in agonist-induced dense granule secretion, but not in alpha-granule secretion. This deficiency in dense granule release was responsible for a reduced platelet aggregation and a marked reduction in thrombus formation. Our results show that in the molecular pathway to secretion, PKD2 is a key component of the PKC-mediated pathway to platelet activation and thrombus formation through its selective regulation of dense granule secretion. (Blood. 2011; 118(2): 416-424)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Cardiac & Cardiovascular Systems

Platelet-derived MMP-2 in the prevention of plaque formation: how many strokes is par?

Judith M. E. M. Cosemans

EUROPEAN HEART JOURNAL (2022)

Article Immunology

Characterization of cerebral small vessel disease by neutrophil and platelet activation markers using artificial intelligence

M. F. A. Karel, M. G. C. H. Roosen, B. M. E. Tullemans, C. Eleana Zhang, J. Staals, J. M. E. M. Cosemans, R. R. Koenen

Summary: Cerebral small vessel disease (cSVD) is a major cause of cognitive decline and stroke. This study found that the neutrophil activation marker MPO is elevated in cSVD patients and highlighted platelet and neutrophil markers as associated with cSVD.

JOURNAL OF NEUROIMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

MicroRNA-26b Attenuates Platelet Adhesion and Aggregation in Mice

Linsey J. F. Peters, Constance C. F. M. J. Baaten, Sanne L. Maas, Chang Lu, Magdolna Nagy, Natalie J. Jooss, Kiril Bidzhekov, Donato Santovito, Daniel Moreno-Andres, Joachim Jankowski, Erik A. L. Biessen, Yvonne Doering, Johan W. M. Heemskerk, Christian Weber, Marijke J. E. Kuijpers, Emiel P. C. van der Vorst

Summary: This study demonstrates for the first time that miR-26b attenuates platelet adhesion and aggregation, possibly through Src and EGFR signaling.

BIOMEDICINES (2022)

Letter Hematology

Platelet procoagulant membrane dynamics: a key distinction between thrombosis and hemostasis?

Ejaife O. Agbani, Ingeborg Hers, Alastair W. Poole

BLOOD ADVANCES (2023)

Letter Hematology

Chemical degradation of BTK/TEC as a novel approach to inhibit platelet function

Justin S. Trory, Attila Munkacsi, Kamila M. Sledz, Jordan Vautrinot, Lucy J. Goudswaard, Molly L. Jackson, Kate J. Heesom, Samantha F. Moore, Alastair W. Poole, Behnam Nabet, Varinder K. Aggarwal, Ingeborg Hers

BLOOD ADVANCES (2023)

Letter Immunology

The Immunological Proteome Resource

Alejandro J. J. Brenes, Angus I. I. Lamond, Doreen A. A. Cantrell

NATURE IMMUNOLOGY (2023)

Article Multidisciplinary Sciences

Human soluble CD39 displays substrate inhibition in a substrate-specific manner

Venkat M. K. Vadlamani, Kavinda K. J. Gunasinghe, Xavier W. Chee, Taufiq Rahman, Matthew T. Harper

Summary: CD39 is a key regulator that metabolizes extracellular ATP and ADP to AMP. This study demonstrates that soluble, recombinant CD39 exhibits substrate inhibition with ADP or ATP as the substrate. High concentrations of ATP or ADP significantly reduce CD39 activity. In contrast, inhibition is not observed with UDP or UTP as substrates. Understanding the substrate inhibition of CD39 is important for interpreting CD39 activity studies and investigations into drugs modulating CD39 activity.

SCIENTIFIC REPORTS (2023)

Article Hematology

Antagonistic Roles of Human Platelet Integrin aIIb beta 3 and Chemokines in Regulating Neutrophil Activation and Fate on Arterial Thrombi Under Flow

Claudia Schoenichen, Samantha J. Montague, Sanne L. N. Brouns, James J. Burston, Judith M. E. M. Cosemans, Kerstin Jurk, Beate E. Kehrel, Rory R. Koenen, Fionnuala Ni Ainle, Valerie B. O'Donnell, Oliver Soehnlein, Steve P. Watson, Marijke J. E. Kuijpers, Johan W. M. Heemskerk, Magdolna Nagy

Summary: This study reveals the key interaction mechanisms between platelets and neutrophils in arterial thrombus formation. Activated platelet integrin αIIbβ3 plays a role in preventing leukocyte adhesion, while platelet-released substances promote neutrophil activation. These findings provide insights for potential pharmacological intervention.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2023)

Article Biochemistry & Molecular Biology

Regulation of Glycoprotein VI-Dependent Platelet Activation and Thrombus Formation by Heparan Sulfate Proteoglycan Perlecan

Isabella Provenzale, Ilaria De Simone, Jonathan M. Gibbins, Johan W. M. Heemskerk, Paola E. J. van der Meijden, Chris I. Jones

Summary: This study investigated the roles of different extracellular matrix proteoglycans in platelet responses and thrombus formation. It was found that one proteoglycan (perlecan) enhanced platelet activation and promoted thrombus formation, but also reduced platelet adhesion under flow. This suggests that proteoglycans play an important role in platelet activation and thrombus formation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Multidisciplinary Sciences

Highly efficient platelet generation in lung vasculature reproduced by microfluidics

Xiaojuan Zhao, Dominic Alibhai, Tony G. Walsh, Nathalie Tarassova, Maximilian Englert, Semra Z. Birol, Yong Li, Christopher M. Williams, Chris R. Neal, Philipp Burkard, Stephen J. Cross, Elizabeth W. Aitken, Amie K. Waller, Jose Ballester Beltran, Peter W. Gunning, Edna C. Hardeman, Ejaife O. Agbani, Bernhard Nieswandt, Ingeborg Hers, Cedric Ghevaert, Alastair W. Poole

Summary: Perfusion of megakaryocytes through the mouse lung vasculature generates a large number of functional platelets. This study reveals the mechanisms of thrombopoiesis in lung vasculature and provides insights for large-scale platelet generation.

NATURE COMMUNICATIONS (2023)

Review Hematology

Illustrated Abstracts of the 5th EUPLAN International Conference

Alexandra Yakusheva, Alexandre Slater, Bernard Payrastre, Cedric Garcia, Giorgia D'Italia, Harriet Allan, Judith M. E. M. Cosemans, Matthew Harper, Meinrad Gawaz, Paul Armstrong, Sara Troitino, Silvia Maria Grazia Trivigno, Ulhas P. Naik, Yotis A. Senis

Summary: This article presents the talks and original investigations conducted at the 5th European Platelet Network International Conference, covering recent advances in platelet and megakaryocyte biology.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2023)

Article Hematology

Consensus report on markers to distinguish procoagulant platelets from apoptotic platelets: communication from the Scientific and Standardization Committee of the ISTH

Emma C. Josefsson, Sofia Ramstrom, Johannes Thaler, Marie Lordkipanidze, COAGAPO Study Grp

Summary: The study aimed to identify a set of markers and/or methods to detect and distinguish procoagulant platelets from apoptotic platelets. Using flow cytometry, a combination of three surface markers, including P-selectin (CD62P), phosphatidylserine (recognized by annexin V), and platelet-specific receptor GPIX (CD42a) or αIIb integrin (CD41, GPIIb), was recommended for differentiation. Procoagulant platelets are positive for all three markers, while apoptotic platelets are positive for annexin V and platelet-specific surface receptor(s) but negative for P-selectin.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2023)

Article Hematology

Alterations in platelet proteome signature and impaired platelet integrin & alpha;IIb & beta;3 activation in patients with COVID-19

Lucy J. Goudswaard, Christopher M. Williams, Jawad Khalil, Kate L. Burley, Fergus Hamilton, David Arnold, Alice Milne, Phil A. Lewis, Kate J. Heesom, Stuart J. Mundell, Andrew D. Davidson, Alastair W. Poole, Ingeborg Hers

Summary: Patients with COVID-19 have altered platelet function, which is associated with increased risk of thrombosis. Platelet protein expression is different in COVID-19 patients, and platelet functional responses are reduced. Platelets in COVID-19 patients also show increased association with neutrophils. These findings suggest that platelet-driven thromboinflammation may contribute to the increased risk of thrombosis in COVID-19 patients.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2023)

Article Hematology

Protein C or Protein S deficiency associates with paradoxically impaired platelet-dependent thrombus and fibrin formation under flow

Sanne L. N. Brouns, Bibian M. E. Tullemans, Cristiana Bulato, Gina Perrella, Elena Campello, Luca Spiezia, Johanna P. van Geffen, Marijke J. E. Kuijpers, Rene van Oerle, Henri M. H. Spronk, Paola E. J. van der Meijden, Paolo Simioni, Johan W. M. Heemskerk

Summary: This study assessed the role of platelets in thrombus and fibrin formation in patients with protein C or protein S deficiency under high-shear flow conditions. The results showed that these patients had impaired platelet activation, thrombus phenotype, and fibrin formation, but unchanged platelet adhesion. The defect may be caused by negative platelet priming.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2022)

Article Hematology

Reversing direct factor Xa or thrombin inhibitors: Factor V addition to prothrombin complex concentrate is beneficial in vitro

Herm Jan M. Brinkman, Frauke Swieringa, Marleen Zuurveld, Alicia Veninga, Sanne L. N. Brouns, Johan W. M. Heemskerk, Joost C. M. Meijers

Summary: The study demonstrates the beneficial effect of combined use of PCC and FVC in reversing DOAC-induced coagulopathy by increasing thrombin generation, improving clot formation, enhancing clot strength and resistance to lysis.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2022)

暂无数据